Skip to main content
. 2021 Apr 29;162(8):bqab088. doi: 10.1210/endocr/bqab088

Table 3.

H3K9 lysine methyltransferase inhibitors in development for cancer therapies and associated mechanisms of action (18)

Reference Compound KMT and methylation target Selectivity IC50 Mechanism of action
Greiner (2005) (153) Chaetocin KMT1A, G9A H3K9me1/me2 Low 0.8 μM Mixed disulfide linkages formed between cysteine residues of enzyme and inhibitor
Chang (2009) (154) BIX-01338 G9A, GLP, and other KMTs Not selective 5-15 μM Unknown
Chang (2009) (154) BIX-01294 G9A and GLP, H3K9me2 Selective 1.7 μM Binds to the substrate binding groove of the enzyme to prevent enzyme and substrate (SAH) interaction
Liu (2009) (155) UNC0224 G9A and GLP, H3K9me2 Selective 15-30 nM Occupation of the G9A lysine binding channel by the 7-dimethylaminopropoxy group
Liu (2010) (156) UNC0321 G9A and GLP, H3K9me2 Selective 63 pM Same as UNC0638 but with a longer ethoxyethyl chain instead of the 3-carbon chain of UNC0638.
Chang (2010) (157) E72 G9A and GLP Selective 100 nM A lysine mimic added to the BIX-01294 structure to inhibit substrate binding
Vedadi (2011) (158) UNC0638 G9A and GLP, H3K9me1/me2 Selective 15-20 nM Competition with the lysine substrate. This inhibitor occupies the substrate binding groove and does not interact with the SAM binding pocket
Liu (2013) (159) UNC0642 G9A and GLP, H3K9me1/me2 Selective < 2.5 nM Same as UNC0638 but with optimized in vivo pharmacokinetic properties
Konze (2014) (160) UNC0965 G9A and GLP H3K9me1/me2 Selective 15-20 nM A biotinylated derivative of UNC0638
Yuan (2012) (161) BRD4770
BRD9539
G9A, GLP, PRC2-EZH2, H3K9me2/me3 Less selective 6.3 nM SAM-competitive inhibitor
Sweis (2014) (162) A-366 G9A and GLP, H3K9me1/me2 Selective 3.3-38 nM Substrate-competitive inhibitor

Abbreviations: GLP, G9A-like protein; IC50, half maximal inhibitory concentration; KMT, lysine methyltransferase; SAH, S-adenosylhomocysteine; SAM, S-adenosyl methionine.